SMS Pharmaceuticals Ltd reports rise in Q1FY24 consolidated PAT to Rs. 8.80 crore

SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 135.8523 crores during the period ended June 30, 2023 as compared to Rs. 150.6819 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 8.8088 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 8.0659 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 1.10 for the period ended June 30, 2023 as compared to Rs. 0.73 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹135.8523 crs	₹150.6819 crs	-9.84%
Net Profit	₹8.8088 crs	₹8.0659 crs	9.21%
EPS	₹1.10	₹0.73	50.68%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs.135.8523 crores during the period ended June 30, 2023 as compared to Rs.65.19 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.8.8088 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.-10.1901 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.1.10 for the period ended June 30, 2023 as compared to Rs.-1.51 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹135.8523 crs	₹65.19 crs	108.39%
Net Profit	₹8.8088 crs	₹-10.1901 crs	186.44%
EPS	₹1.10	₹-1.51	172.85%

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 122.60 as compared to the previous close of Rs. 122.10. The total number of shares traded during the day was 78159 in over 1187 trades.

The stock hit an intraday high of Rs. 136.00 and intraday low of 118.60. The net turnover during the day was Rs. 10063490.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals Q1FY24 ResultUpdate